Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid responseAkito Nakamura, Takahito Hara, Yoshinori Satomi et al.|Proceedings of the National Academy of Sciences|2018Cited by 172
Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditionsSaomi Murai, Takahito Hara, Ayumi Ando et al.|Oncogenesis|2017Cited by 82
Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within TumorsTakatsugu Okegawa, Takahito Hara, Megumi Morimoto et al.|EBioMedicine|2017Cited by 69
Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitorsSatoshi Kitazawa, Takahito Hara, Shunsuke Ebara et al.|Oncotarget|2017Cited by 34
In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitorSatoru Nishizawa, Takahito Hara, Hiroyuki Sumi et al.|European Journal of Pharmacology|2017Cited by 25